{
  "retracted": false,
  "timestamp": 1440115200000,
  "updates": [
    {
      "timestamp": 1550216923064,
      "identifier": {
        "doi": "10.1371/journal.pone.0136515"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1371/journal.pone.0133968"
  },
  "publisher": "Public Library of Science (PLoS)",
  "title": "Correction: Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA"
}
